ovarian hyperstimulation syndrome
Jump to navigation
Jump to search
Etiology
- iatrogenic complication of ovarian stimulation treatments for in vitro fertilization (most common)
- spontaneous
Pathology
- increased capillary permeability resulting from release of vasoactive mediators from maturation of multiple ovarian follicles
- vascular endothelial growth factor is thought to be one of the mediators
- multiple serous & hemorrhagic follicular cysts lined by luteinized cells (hyperreactio luteinalis)
Genetics
- autosomal recessive
- associated with defects in FSHR
Clinical manifestations
- acute onset third spacing of fluid
- pleural effusions (generally bilateral)
- ascites
- peripheral edema
- hemoconcentration in severe cases
- vary from abdominal distension & discomfort to potentially life-threatening, massive ovarian enlargement & capillary leak with fluid sequestration
Laboratory
Management
- supportive care, self-limited condition
More general terms
References
- ↑ UniProt http://www.uniprot.org/uniprot/P23945.html
- ↑ Shmorgun D, Claman P No-268-The Diagnosis and Management of Ovarian Hyperstimulation Syndrome. J Obstet Gynaecol Can. 2017 Nov;39(11):e479-e486 PMID: https://www.ncbi.nlm.nih.gov/pubmed/29080733
- ↑ Timmons D, Montrief T, Koyfman A, Long B. Ovarian hyperstimulation syndrome: A review for emergency clinicians. Am J Emerg Med. 2019 Aug;37(8):1577-1584. Epub 2019 May 7. PMID: https://www.ncbi.nlm.nih.gov/pubmed/31097257 Review.
- ↑ Kaiser UB The Pathogenesis of the Ovarian Hyperstimulation Syndrome. N Engl J Med. 2003, 349:8 PMID: https://www.ncbi.nlm.nih.gov/pubmed/12930924 https://www.nejm.org/doi/pdf/10.1056/NEJMp038106